Company Overview

Qbiogene, a subsidiary of MP Biomedicals, is a biotechnology research products supply company, focusing on the development of novel research reagents for the Human Genomics and Molecular Biology markets including fields associated with advances in genetic engineering and recombinant technologies. Qbiogene is dedicated to providing novel and innovative research tools of the highest quality to assist the world's scientists in these next steps towards innovative discoveries.

The company obtained and holds exclusive worldwide license for six technologies and one distribution licence. Eight product groups are currently on the market.

By establishing and maintaining a close communication network with the research community, the scientists themselves have developed working at the laboratory bench. In combination with the will minimize development time and costs to maximize the timely availability of novel research products, reagents and kits on a worldwide basis. Qbiogene continues to seek for licensing and commercial development, new rapid and efficient methods for application in molecular biology. The Company development, new rapid and efficient methods for application in molecular biology. The Company has several distribution agreement and is in process of completing its international distribution network.

Qbiogene is dedicated to providing novel and innovative research tools. We offer Adenovirus Expression System, AutoFluorescent Visualization Proteins (AFP), Positive Selection Vector, Site Directed Mutagenesis, Yeast Lytic Enzyme, sets of Primers & non radioactive Probes, Restriction & Modification Enzymes and Baculovirus Expression System.

Company Information

Additional Details

Legal Name: Qbiogne Inc.

Number of Employees: 250

Contacts

Services

• Biotechnology
• Custom Adenovirus Services
• Viral Vectors

  Contract manufacturing of viral vectors for gene therapy clinical trials.

Products

• Adeasy
• Adeno-quest
• Autofluorescent Proteins

  - Quantum's AFPS (AutoFluoresecent Proteins) are variant of the ultimate source of fluorescent light emission in the jellyfish Aequorea victoria. Modifications of the chromophore sequences of wtGFP allowed the production of bright and efficient Blue, Green or Red-shifted fluorescent proteins. AFPs provide flexible tools for protein localization and trafficking studies in living cells of organisms.

• Quanta-enzyme

  High Perfromance restriction endonucleases and DNA modification enzymes. We provide rare cutters infrequent cutters and frequent cutters restriction endonucleases.

• Quantazyme Ylg

  - Quantazyme ylg is a Yeast Lytic B-1, 3-Glucanase, purified from an E. coli strain carrying a recombinant lytic B-1, 3-Glucanase gene from an Arthrobacter species on an expression plasmid.

• Quanttox

  Quantum Biotechnologies offers a pGATA positive selection vector based on the inactivation of a toxic protein. The background is therefore 'killed' and only bacterial cells containing recombinant proteins are able to grow.

Additional Information